Klostermann; Stefan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Klostermann; Stefan.The latest application filed is for "method for the production of an antibody".
Company Profile
15.14.37
- Klostermann; Stefan - Neuried DE
- Klostermann; Stefan - Penzberg DE
Patent Activity
| Patent | Date |
|---|---|
| Method For The Production Of An Antibody App 20220220500 - Goepfert; Ulrich ; et al. | 2022-07-14 |
| Anti-rabbit Cd19 Antibodies And Methods Of Use App 20220135672 - Haas; Alexander ; et al. | 2022-05-05 |
| Antibodies binding to HLA-A2/WT1 Grant 11,192,957 - Benz , et al. December 7, 2 | 2021-12-07 |
| Multispecific Antibodies App 20210309730 - SCHAEFER; Wolfgang ; et al. | 2021-10-07 |
| Bispecific T cell activating antigen binding molecules Grant 11,117,965 - Ast , et al. September 14, 2 | 2021-09-14 |
| Antibodies binding to HLA-A2/MAGE-A4 App 20210230278 - Weinzierl; Tina ; et al. | 2021-07-29 |
| Anti-hla-g Antibodies And Use Thereof App 20210147553 - DENGL; Stefan ; et al. | 2021-05-20 |
| Multispecific Antibodies And Use Thereof App 20210147554 - DENGL; Stefan ; et al. | 2021-05-20 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20210070882 - BACAC; Marina ; et al. | 2021-03-11 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20200347147 - BACAC; Marina ; et al. | 2020-11-05 |
| Bispecific T cell activating antigen binding molecules Grant 10,766,967 - Bacac , et al. Sep | 2020-09-08 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20200231673 - AST; Oliver ; et al. | 2020-07-23 |
| Three-dimensional Structure-based Humanization Method App 20200223945 - AUER; Johannes ; et al. | 2020-07-16 |
| Method for discovery of alternative antigen specific antibody variants App 20200216880 - GEORGES; Guy ; et al. | 2020-07-09 |
| Bispecific T cell activating antigen binding molecules Grant 10,611,840 - Ast , et al. | 2020-04-07 |
| Bispecific T cell activating antigen binding molecules Grant 10,611,841 - Ast , et al. | 2020-04-07 |
| Anti-hla-g Antibodies And Use Thereof App 20200102389 - FISCHER; Jens ; et al. | 2020-04-02 |
| Method For Improving Antibody Stability App 20200066372 - KETTENBERGER; Hubert ; et al. | 2020-02-27 |
| Method for improving antibody stability Grant 10,418,126 - Kettenberger , et al. Sept | 2019-09-17 |
| Antibodies binding To HLA-A2/WT1 App 20190248916 - Benz; Joerg ; et al. | 2019-08-15 |
| Bispecific antibodies against CD3 and BCMA Grant 10,253,104 - Vu , et al. | 2019-04-09 |
| Anti-cd3xrob04 Bispecific T Cell Activating Antigen Binding Molecules App 20180282410 - AST; Oliver ; et al. | 2018-10-04 |
| Sequence dependent aggregation Grant 10,047,162 - Kettenberger , et al. August 14, 2 | 2018-08-14 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20180222980 - AST; Oliver ; et al. | 2018-08-09 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20180222981 - AST; Oliver ; et al. | 2018-08-09 |
| Non-cross-reactive anti IgG antibodies Grant 9,957,331 - Essig , et al. May 1, 2 | 2018-05-01 |
| Method For The Expression Of Polypeptides Using Modified Nucleic Acids App 20180100006 - Klostermann; Stefan ; et al. | 2018-04-12 |
| Bispecific T cell activating antigen binding molecules Grant 9,914,776 - Ast , et al. March 13, 2 | 2018-03-13 |
| Multispecific Antibodies App 20170349669 - IMHOF-JUNG; SABINE ; et al. | 2017-12-07 |
| Bispecific Antibodies Against Cd3epsilon And Bcma App 20170306036 - VU; Minh Diem ; et al. | 2017-10-26 |
| Bispecific Antibodies Against Cd3epsilon And Ror1 App 20170306018 - VU; MINH DIEM ; et al. | 2017-10-26 |
| Bispecific Antibodies Against Cd3epsilon And Ror1 For Use In The Treatment Of Ovarian Cancer App 20170306044 - VU; MINH DIEM ; et al. | 2017-10-26 |
| Anti-human IgG1 antibody Grant 9,766,251 - Essig , et al. September 19, 2 | 2017-09-19 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20170190783 - Bacac; Marina ; et al. | 2017-07-06 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20170174786 - Bacac; Marina ; et al. | 2017-06-22 |
| Bispecific T cell activating antigen binding molecules App 20170114146 - Klein; Christian ; et al. | 2017-04-27 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20170096485 - BACAC; Marina ; et al. | 2017-04-06 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20170096495 - BACAC; Marina ; et al. | 2017-04-06 |
| Method For Improving Antibody Stability App 20160275238 - KETTENBERGER; Hubert ; et al. | 2016-09-22 |
| Bispecific T Cell Activating Antigen Binding Molecules App 20160075785 - Ast; Oliver ; et al. | 2016-03-17 |
| Sequence Dependent Aggregation App 20160068602 - KETTENBERGER; HUBERT ; et al. | 2016-03-10 |
| ANTI-HUMAN IgG1 ANTIBODY App 20150323543 - ESSIG; ULRICH ; et al. | 2015-11-12 |
| Multispecific Antibodies App 20150315296 - SCHAEFER; WOLFGANG ; et al. | 2015-11-05 |
| Sequence dependent aggregation Grant 9,150,641 - Kettenberger , et al. October 6, 2 | 2015-10-06 |
| Method For The Expression Of Polypeptides Using Modified Nucleic Acids App 20150246961 - KLOSTERMANN; Stefan ; et al. | 2015-09-03 |
| ANTI-HUMAN IgG1 ANTIBODY App 20140038210 - ESSIG; ULRICH ; et al. | 2014-02-06 |
| Sequence Dependent Aggregation App 20130065277 - Kettenberger; Hubert ; et al. | 2013-03-14 |
| Non-cross-reactive Anti Igg Antibodies App 20120208216 - Essig; Ulrich ; et al. | 2012-08-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 